Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.
Zara IzadiMilena A GianfrancescoAlfredo AguirreAnja StrangfeldElsa F MateusKimme L HyrichLaure GossecLoreto CarmonaSaskia Lawson-ToveyLianne Kearsley-FleetMartin SchaeferAndrea M SeetGabriela SchmajukLindsay JacobsohnPatricia P KatzStephanie RushSamar Al EmadiJeffrey A SparksTiffany Y-T HsuNaomi J PatelLeanna Marderian WiseEmily GilbertAli Duarte GarciaMaria O Valenzuela-AlmadaManuel F Ugarte-GilSandra Lucia Euzébio RibeiroAdriana de Oliveira MarinhoLilian David de Azevedo ValadaresDaniela Di GiuseppeRebecca HasseliJutta G RichterAlexander PfeilTim SchmeiserCarolina A IsnardiAlvaro A Reyes TorresGelsomina AlleVerónica SauritAnna ZanettiGreta CarraraJulien LabreucheThomas BarnetcheMuriel HerasseSamira PlassartMaria Jose SantosAna Maria RodriguesPhilip C RobinsonPedro M MachadoEmily SirotichJean W LiewJonathan S HausmannPaul SufkaPhilip C RobinsonSuleman BhanaWendy CostelloZachary S WallaceRebecca Graingernull nullPublished in: ACR open rheumatology (2022)
We were able to predict ARDS with good sensitivity using information readily available at COVID-19 diagnosis. The proposed risk score calculator has the potential to guide risk stratification for treatments, such as monoclonal antibodies, that have potential to reduce COVID-19 disease progression.